Muñoz M, García-Vallejo J J, Sempere J M, Romero R, Olalla E, Sebastián C
GIEMSA, Department of Biochemistry, School of Medicine, University of Málaga, Málaga, Spain.
Eur Spine J. 2004 Jul;13(4):367-73. doi: 10.1007/s00586-003-0641-9. Epub 2003 Nov 21.
In orthopaedic surgery, perioperative administration of non-steroidal anti-inflammatory drugs has been shown to reduce postoperative pain and analgesic consumption. In addition, preoperative administration of ibuprofen has proved to reduce interleukin-6 (IL-6) release, while that of ranitidine reduced postoperative IL-6-induced C-reactive protein synthesis in patients undergoing abdominal surgery. However, it has not been established whether the preoperative administration of both types of drugs may reduced the postoperative inflammatory reaction after instrumented spinal surgery. Accordingly, our objective was to investigate the effects of preoperative treatment with naproxen plus famotidine on the postoperative systemic inflammatory reaction in patients undergoing instrumented lumbar spinal surgery. Forty consecutive patients scheduled for elective instrumented spinal fusion were alternately assigned to receive either naproxen (500 mg/day, p.o.) plus famotidine (40 mg/day, p.o.) for 7 days before operation, or no adjuvant treatment. Haematological parameters, acute phase proteins, complement fractions, immunoglobulins and cytokines were determined 7 days and immediately before surgery, and on days 0, 1, 2 and 7 after surgery. Haematological parameters, clinical data, duration of surgery, blood loss, perioperative blood transfusion and postoperative complications were similar in the two groups, although pretreated patients showed lower increases in body temperature and required less analgesic medication. Compared with preoperative levels, IL-6 levels were significantly increased postoperatively in all patients with no differences between groups. C-reactive protein, alpha(1)-acid-glycoprotein and haptoglobin levels were also significantly increased postoperatively in all patients; however, they were significantly lower in pretreated patients. In conclusion, perioperative treatment with naproxen plus famotidine was well tolerated and reduced the acute phase response after instrumented spinal surgery. However, further research is needed to determine the best dose and timing of preoperative treatment administration, and to correlate these changes with long-term clinical results.
在骨科手术中,围手术期使用非甾体类抗炎药已被证明可减轻术后疼痛并减少镇痛药的用量。此外,术前使用布洛芬已被证明可减少白细胞介素-6(IL-6)的释放,而雷尼替丁可减少腹部手术患者术后IL-6诱导的C反应蛋白合成。然而,术前同时使用这两种药物是否能减轻器械辅助脊柱手术后的术后炎症反应尚未得到证实。因此,我们的目的是研究术前使用萘普生加雷尼替丁对接受器械辅助腰椎手术患者术后全身炎症反应的影响。40例计划进行择期器械辅助脊柱融合术的连续患者被交替分配,一组在术前7天接受萘普生(500毫克/天,口服)加雷尼替丁(40毫克/天,口服),另一组不接受辅助治疗。在术前7天、手术前即刻以及术后第0、1、2和7天测定血液学参数、急性期蛋白、补体成分、免疫球蛋白和细胞因子。两组患者的血液学参数、临床数据、手术时间、失血量、围手术期输血情况及术后并发症相似,尽管接受预处理的患者体温升高幅度较小且所需镇痛药较少。与术前水平相比,所有患者术后IL-6水平均显著升高,两组间无差异。所有患者术后C反应蛋白、α1-酸性糖蛋白和触珠蛋白水平也显著升高;然而,接受预处理的患者这些指标显著较低。总之,萘普生加雷尼替丁围手术期治疗耐受性良好,可减轻器械辅助脊柱手术后的急性期反应。然而,需要进一步研究以确定术前治疗给药的最佳剂量和时机,并将这些变化与长期临床结果相关联。